Committees and Work Groups
The Department of Health and Human Services and the Division of Medical Assistance are committed to working with beneficiaries, caregivers, providers, associations and other stakeholders to improve health care in North Carolina. Below is information for committees and work groups engaged in this collaborative process. Click on a group title for more information.
Dual Eligibles Advisory Committee
Medical Care Advisory Committee (MCAC)
North Carolina Drug Utilization Review Board
Money Follows the Person (MFP)
Personal Care Services (PCS)
Preferred Drug List Review Panel
The Dual Eligibles Advisory Committee, established according to Session Law 2015-245, provides advice to the Department of Health and Human Services as it developes a long-term strategy to cover dual eligibles under Medicaid reform. The Department will report the strategy to the Joint Legislative Oversight Committee on Medicaid and NC Health Choice by Jan. 31, 2017.
The Advisory Committee meets monthly. Meetings are open to the public.
Thursday, July 28, 2016
11:00 a.m. to 2:00 p.m.
McKimmon Conference & Training Center
1101 Gorman St.
Raleigh, NC 27606
For a complete meeting schedule, member list, agendas, presentations and other information, visit the Dual Eligibles Advisory Committee web page.
Federal law requires that state Medicaid agencies have a Medical Care Advisory Committee (MCAC). MCAC members advise NC Medical Assistance on health and medical care services that may be covered by the NC Medicaid program. This includes current policy revisions and accessing services. The MCAC is advisory and does not set policy. Meetings are open to the public.
The MCAC is established and governed by federal and state regulations:
- Sec. 1902(a)(22)
- 42 CFR 431.11, Organization for administration
- NCGS 143B-10, Powers and duties of heads of principal departments
The MCAC has members from the 13 congressional districts plus seven at-large seats. Each member is asked to serve a three-year term, which may vary if a seat vacated and filled before the end of the term. MCAC members are appointed by the Secretary of Health and Human Services, and consists of:
- Board-certified physicians and other representatives of the health profession who are familiar with the medical needs of, and resources available for, the care of low-income groups
- Director of the public welfare department or the public health department
- Recipients and consumer organizations, such as labor unions, organizations representing the poor, civil rights organizations, business, consumer cooperatives and unaffiliated private citizens
- Government, state and county medical societies; professional and provider associations; health insurance industry; and health and medical education
- Members must be willing to advise DHHS Medical Assistance on the impact of proposed initiatives and changes on the Medicaid Program
- Members meet in person in a Raleigh location at least quarterly for approximately three hours, typically 9:00 am - 12:00 pm
- Non-state employee members receive a $15 compensation for each day of service, round-trip mileage reimbursement of 25 cents per mile, and applicable subsistence according to state guidelines. If paid overnight accommodations are required, a receipt for lodging must be attached to the reimbursement request. Necessary forms will be provided at each meeting to claim reimbursement.
|Congressional District Represented||Member Name|
|1||Kim A. Schwartz|
|2||Samuel B. Clark|
|3||David T. Tayloe III|
|4||Carol Yates Day|
|5||William T. Cockerham|
|7||Marilyn R. Pearson|
|8||Stephen A. Small|
|10||Derek T. Pantiel|
|12||Billy R. West, Jr.|
|13||Linda D. Burhans|
|At - Large||C. Thomas Johnson III|
|At - Large||Ted W. Goins|
|At - Large||Gary R. Massey, Chair|
|At - Large||David D. Sumpter|
|At - Large||Paula Cox Fishman|
|At - Large||Benjamin Koren|
2017 Meeting Schedule
2015 and 2016 Meeting Information
The NC Medicaid Drug Utilization Review (DUR) program for outpatient drugs ensures Medicaid recipients receive appropriate, medically necessary prescriptions that are unlikely to result in adverse medical events.
NC DUR Board meetings are held quarterly in the following location. They are open to the public.
Health and Human Services, Medical Assistance
Kirby Building, Room 297
1985 Umstead Drive
Raleigh, NC 27603
Thursday, January 26, 1-3 p.m.
Thursday, April 27, 1-3 p.m.
Thursday, July 27, 1-3 p.m.
Thursday, October 26, 1-3 p.m.
Join the MFP Roundtable, receive MFP updates and meeting notices. If you are interested in supporting MFP, complete and submit the Volunteer Form or call for information
Phone: 919-855-4265 or 855-761-9030
The Personal Care Services (PCS) Stakeholder Group provides citizens interested in the development and implementation of Personal Care Services with the opportunity to collaborate and share recommendations. The N.C. Department of Health and Human Services meets monthly with community stakeholders to share project status, gather input and identify next steps.
To join the PCS Stakeholder Group, call 919-855-4360 or send an email to PCS_Program_Questions@dhhs.nc.gov.
PCS Stakeholder Meeting Information
When: Third Thursday of each month
Time: 1 p.m. - 3 p.m.
Where: Dorothea Dix Campus
Kirby Building, Room 297
1935 Umstead Drive
Raleigh NC 27603
Request a topic for discussion (please submit at least 1 week in advance of the meeting date)
- Jan. 19, 2016
Nov. 17, 2016
Sept. 15, 2016
July 21, 2016
June 16, 2016
The Medicaid and Health Choice Preferred Drug List (PDL) Review Panel was established by DHHS to conduct open meetings to discuss recommended policies and procedures related to the PDL and to address the public comments that were received during the PDL comment period. The administration and review of the North Carolina Medicaid and Health Choice PDL follows the Preferred Drug List Review Panel Guidelines and Procedures.
|Sept. 29, 2016||1 p.m. - 5 p.m.|| The State Library Building
109 E. Jones St.
Raleigh, NC 27601
To sign up to speak at the PDL Review Meeting, send an email to DMA.PDLReviewMeeting@lists.ncmail.net by 5 p.m. on Sept. 27, 2016. Include the name of the speaker, the represented organization and the drug name. You may attach any clinical information about the drug you wish the PDL Panel to review beforehand. Presentations are allowed only in the drug classes with changes and should not exceed three minutes.
Recommendations and Reports
PDL Panel Members
|John Stancil||Pharmacist||Pharmacy Director, Division of Medical Assistance|
|Dr. Seung Kim||Physician||Old North State Medical Society|
|Dr. Ann McGee||Pharmacist||Hospital-Based Pharmacy|
|Dr. Abigail Deveries||Physician||Community Care of North Carolina|
|Dr. Casey Johnson||Pharmacist||N.C. Association of Pharmacists|
|Dr. Anna Miller-Fitzwater||Physician||N.C. Pediatric Society|
|Dr. Theodore Zarzar||Physician||N.C. Psychiatric Association|
|Dr. Byron J. Hoffman||Physician||N.C. Chapter of the American College of Physicians|
|Dr. Robert L. (Chuck) Rich Jr.||Physician||N.C. Academy of Family Physicians|
|Dr. Andreas Maetzel||Physician||Research-Based Pharmaceutical Company|
|Dr. Lawrence Greenblatt||Physician||N.C. Physician Advisory Group Pharmacy and Therapeutics Committee|